G. L. Yahaya et al. / Open Journal of Preventive Medicine 3 (2013) 58-63
62
blood glucose levels and can benefit from targeted ran-
dom blood glucose testing as part of a 2-stage screening
process that affords them the opportunity to discuss the
results and management options with a primary care pro-
vider in a clinical setting. Research is needed to deter-
mine whether the extra years of treatment that individu-
als will receive if screening determines their pre-diabetic
state will result in significantly improved diabetes related
cardiovascula r out comes in a cost-effe ct i ve manner.
5. KEY MESSAGES
• Spouses of diabetic patients with a greater tendency
to higher random blood glucose levels can benefit from
targetted screening in a clin ical setting.
• Random blood glucose measurements are an effec-
tive screening tool in controlled clinical setting s.
REFERENCES
[1] Miranda, J.J., Kinra, S., Casas, JP.., Smith, G.D. and
Ebrahim, S. (2008) Non-communicable diseases in low-
and middle-income countries: Context, determinants and
health policy. Tropical Medicine & International Health,
13, 1225-1234.
d oi: 10. 1111/j .1 3 65 -3156.2008.02116.x
[2] WHO (2005) Preventing chronic disease: A vital invest-
ment. WHO, Geneva.
[3] Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T.
and Murray, C.J. (2006) Global and regional burden of
disease and risk factors: Systematic analysis of popula-
tion health data. Lancet, 367, 1747-1757.
doi:10.1016/S0140-6736(06)68770-9
[4] Kinnear, T.W. (1963) The pattern of diabetes mellitus in a
nigeria teaching hospital. East African Medical Journal,
40, 288-294.
[5] Nyenwe, E.A., Odia, O.J., Ihekwaba, A.E., Ojule, A. and
Babatunde, S. (2003) Type 2 diabetes in adult Nigerians:
A study of its prevalence and risk factors in Port Harcourt,
Nigeria. Diabetes Research and Clinical Practice, 62,
177-185. doi:10.1016/j.diabres.2003.07.002
[6] Shaw, J.E., Sicree, R.A. and Zimmet, P.Z. (2009) Global
estimates of the prevalence of diabetes for 2010 and 2030.
Diabetes Research and Clinical Practice, 87, 4-14.
doi:10.1016/j.diabres.2009.10.007
[7] Gwatkin, D., Guillot, M. and Heuveline, P. (1999) The
burden of disease among the global poor. Lancet, 354,
586-589. doi:10.1016/S0140-6736(99)02108-X
[8] Di Castelnuovo, A., Quacquaruccio, G., Donati, M.B., de
Gaetano, G. and Iacoviello, L. (2009) Spousal concor-
dance for major coronary risk factors: A systematic re-
view and meta-analysis. American Journal of Epidemi-
ology, 169, 1-8. doi:10.1093/aje/kwn234
[9] Brenn, T. (1993) Adult family members and their resem-
blance of coronary heart disease risk factors: The cardio-
vascular disease study in Finnmark. European Journal of
Epidemiology, 13, 623-630.
doi:10.1023/A:1007333919898
[10] Freidman, G.D. and Quesenberry, C.P. (1999) Spousal
concordance for cancer incidence: A cohort study. Cancer,
86, 2413-2419.
doi:10.1002/(SICI)1097-0142(19991201)86:11<2413::AI
D-CNCR32>3.0.CO;2-J
[11] Kolonel, L.N. and Lee, J. (1981) Husband-wife corre-
spondence in smoking, drinking and dietary habit. The
American Journal of Clinical Nutrition, 1, 99-104.
[12] Hippisley-Cox, J., Coupland, C., Pringle, M., Crown, N.
and Hammersley, V. (2002) Married couples’ risk of the
same disease: Cross sectional study. British Medical
Journal, 325, 636-638.
doi:10.1136/bmj.325.7365.636
[13] Khan, A., Lasker, S.S. and Chowdhury, T.A. (2003) Are
spouses of patients with type-2 diabetes at increased risk
of developing diabetes? Diabetes Care, 26, 710-712.
doi:10.2337/diacare.26.3.710
[14] American Diabetes Association (Position Statement)
(2003) Screening for type 2 diabetes. Diabetes Care, 26,
S21-S24. doi:10.2337/diacare.26.2007.S21
[15] Beaglehole, R., Epping-Jordan, J., Patel, V., Chopra, M.,
Ebrahim, S., Kidd, M. and Haines, A. (2008) Improving
the prevention and management of chronic disease in
low-income and middle-income countries: A priority for
primary health care. Lancet, 372, 940-949.
doi:10.1016/S0140-6736(08)61404-X
[16] Waugh, N., Scotland, G., McNamee, P., Gillett, M., Bren-
nan, A., Goyder, E., Williams, R. and John, A. (2007)
Screening for type 2 diabetes: Literature review and eco-
nomic modelling. Health Technology Assessment, 11, 1-
125.
[17] Backholer, K., Chen, L. and Shaw, J. (2012) Screening
for diabetes. Pathology, 44, 110-114.
doi:10.1097/PAT.0b013e32834e8e12
[18] Somannavar, S., Ganesan, A., Deepa, M., DAtta, M. and
Mohan, V. (2009) Random capillary blood glucose cut
points for diabetes and prediabetes derived from commu-
nity-based opportunistic screening in India. Diabetes
Care, 32, 641-643. doi:10.2337/dc08-0403
[19] Trejo-Arteaga, J.M., López-Carmona, J.M., Rodríguez-
Moctezuma, J.R., Peralta-Pedrero, M.L., Escudero-Mon-
tero, R., Gutiérrez Escolano, M.F. (2008) Risk of glucose
metabolism changes in spouses of Mexican patients with
type 2 diabetes. Medicina Clínica, 131, 605-608 (Article
in Spanish). doi:10.1157/13127917
[20] McCance, D.R., Hanson, R.L., Charles, M.-A., Jacobsson,
L.T.H., Pettitt, D.J., Bennett, P.H., et al. (1994) Compari-
son of tests for glycated haemoglobin and fasting and two
hour plasma glucose concentrations as diagnostic meth-
ods for diabetes. British Medical Journal, 308, 1323-
1328. doi:10.1136/bmj.308.6940.1323
[21] Diabetes Control and Complications Trial Research
Group (1993) The effect of intensive treatment of diabe-
tes on the development and progression of long term
complications in insulin-dependent diabetes mellitus. The
New England Journal of Medicine, 329, 977-986.
doi:10.1056/NEJM199309303291401
Copyright © 2013 SciRes. OPEN ACCE SS